These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 23402999)

  • 21. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
    Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of protease-activated receptor 4 in human gastric cancer.
    Zhang Y; Yu G; Jiang P; Xiang Y; Li W; Lee W; Zhang Y
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1277-83. PubMed ID: 21635966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
    Tögel L; Nightingale R; Wu R; Chüeh AC; Al-Obaidi S; Luk I; Dávalos-Salas M; Chionh F; Murone C; Buchanan DD; Chatterton Z; Sieber OM; Arango D; Tebbutt NC; Williams D; Dhillon AS; Mariadason JM
    Sci Rep; 2018 Jan; 8(1):1767. PubMed ID: 29379130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.
    Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T
    Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
    Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
    Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
    Deng H; Guo Y; Song H; Xiao B; Sun W; Liu Z; Yu X; Xia T; Cui L; Guo J
    Gene; 2013 Apr; 518(2):351-9. PubMed ID: 23333942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics.
    Ke X; McKnight RA; Caprau D; O'Grady S; Fu Q; Yu X; Callaway CW; Albertine KH; Lane RH
    Physiol Genomics; 2011 Oct; 43(20):1160-9. PubMed ID: 21828247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China.
    Huang L; Zhang KL; Li H; Chen XY; Kong QY; Sun Y; Gao X; Guan HW; Liu J
    Hum Pathol; 2006 Dec; 37(12):1557-67. PubMed ID: 16949912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG methylation of transcription factor 4 in gastric carcinoma.
    Joo JK; Kim SH; Kim HG; Kim DY; Ryu SY; Lee KH; Lee JH
    Ann Surg Oncol; 2010 Dec; 17(12):3344-53. PubMed ID: 20585880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
    Ling Y; Shi X; Wang Y; Ling X; Li Q
    Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
    Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
    Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.